We are live on
!
Find out more
SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
144 hedge funds and large institutions have $2.82B invested in SpringWorks Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
42% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 43
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
1% more funds holding
Funds holding: 142 → 144 (+2)
0.53% more ownership
Funds ownership: 91.76% → 92.29% (+0.53%)
1% less capital invested
Capital invested by funds: $2.86B → $2.82B (-$38.7M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.7M
Holders
144
Holders Change
+2
Holders Change %
+1.41%
% of All Funds
2.22%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
19
Increased
61
Reduced
43
Closed
16
Calls
–
Puts
$2.7M
Net Calls
-$2.7M
Net Calls Change
-$2.77M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$25.6M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$24.8M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$21.6M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$20.8M |
| 5 |
AG
Artal Group
Luxembourg
|
+$16.5M |